alpha-lactalbumin breast cancer vaccine
Term · Oncology and biomedicine · MLC-T-ONC-009986
A breast cancer vaccine consisting of recombinant human alpha-lactalbumin (aLA), with potential immunostimulatory and antineoplastic activities. Upon administration, aLA breast cancer vaccine may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells that express the aLA protein, resulting in tumor cell lysis. aLA is expressed in many types of breast cancer, including triple negative breast cancer (TNBC), while normally present in healthy breast tissues only during lactation.
| Identifier | MLC-T-ONC-009986 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | a-lactalbumin Vaccine; aLA breast cancer vaccine; alpha-lactalbumin protein vaccine; alpha-lactalbumin vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009986",
"term": "alpha-lactalbumin breast cancer vaccine",
"field": "Oncology and biomedicine",
"definition": "A breast cancer vaccine consisting of recombinant human alpha-lactalbumin (aLA), with potential immunostimulatory and antineoplastic activities. Upon administration, aLA breast cancer vaccine may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells that express the aLA protein, resulting in tumor cell lysis. aLA is expressed in many types of breast cancer, including triple negative breast cancer (TNBC), while normally present in healthy breast tissues only during lactation.",
"synonyms": [
"a-lactalbumin Vaccine",
"aLA breast cancer vaccine",
"alpha-lactalbumin protein vaccine",
"alpha-lactalbumin vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alpha-lactalbumin-breast-cancer-vaccine/"
}
Record 889 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.